New biotherapeutic protects gut microbiome from harmful effects of antibiotics
A team of scientists at Harvard University and the Massachusetts Institute of Technology (MIT) collaborated to develop a live biotherapeutic product (eLBP) that, when given together with commonly used antibiotics, protects the gut microbiome from adverse disturbance.